A Study to Assess the Safety, Tolerability, PK and PD of WIN378 in Participants With Moderate - Severe COPD
Part of paid clinical trials in Miami Lakes, Florida.
- Sponsor
- Windward Bio
- Study ID
- NCT07646587
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- WIN378 — DRUGWIN378 is a fully human, long-acting monoclonal antibody that targets the ligand of thymic stromal lymphopoietin (TSLP), blocking its activity and thereby reducing airway inflammation and improving COPD control over an extended dosing interval
- Placebo — DRUGPlacebo matching WIN378
Study Details
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD). WIN378 blocks the action of a protein called TSLP that causes inflammation in the lung and may contribute to COPD control and symptoms. The study will test how doses of WIN378 are handled by the body (pharmacokinetics) and assess the safety of the medicine and markers of COPD inflammation in exhaled breath and blood, lung function and COPD control (pharmacodynamics)
Key Dates
- Start date
- Jun 2, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 17, 2027
- Completion
- Jan 7, 2028
Study Design
- Enrollment
- 105 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: WIN378 Dose 1WIN378 SC injections will be administered
- Experimental: WIN378 Dose 2WIN378 SC injections will be administered
- Experimental: PlaceboPlacebo SC injections will be administered
Primary Outcome Measure
Number of participants with Adverse Events (AEs) [ Time Frame: Week 0 - Week 36 ]
Central Contacts
- Juliana Hutchinson, MSc+4161 551 75 75
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| WB Contracted Clinical Research Site | Miami Lakes | Florida | 33014 | - |
| WB Contracted Clinical Research Site | Charlotte | North Carolina | 28277 | - |
| WB Contracted Clinical Research Site | McKinney | Texas | 75069 | - |
Find similar trials in Miami Lakes, FL
Related Studies
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePHASE3 · Recruiting · AstraZeneca · Athens, Alabama
- Photon-counting CT in Chest ImagingRecruiting · Duke University · Durham, North Carolina
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With HypoxemiaPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina
- Validation of Chronic Obstructive Pulmonary Disease (COPD) AlgorithmRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina